FINWIRES · TerminalLIVE
FINWIRES

Lotus Horizon Expects Slide to Loss in Q1 2026

By

-- Lotus Horizon (HKG:6063) said it expects HK$3.5 million in consolidated net loss for the first quarter of 2026, compared with a profit of HK$3.2 million a year earlier, according to a Hong Kong filing Thursday.

The construction engineering services firm's shares gained over 1% in Friday morning trade.

The firm attributed the slide into loss to a 13% year-on-year decrease in revenue due to slow progress on construction projects.

Related Articles

Asia

Xili Intelligent Tech Wins State Grid's Metering Equipment Tender

Hangzhou Xili Intelligent Technology (SHA:688616) was selected as one of the winning bidders for State Grid Corporation of China's public tender for metering equipment, according to a Shanghai bourse filing on Friday.The winning bid amount totals 162 million yuan, the Chinese smart meters manufacturer said.The winning package includes Class A single-phase smart electricity meters, Class B and C three-phase smart electricity meters, smart integrated terminals, metering low-voltage current transformers, 10-35-kilovolt metering current and voltage transformers and 10kV metering combined transformers.

$SHA:688616
Asia

Far EasTone Logs NT$3.7 Billion in Q1 Profit

Far EasTone Telecommunications (TPE:4904) reported profit attributable to owners of NT$3.71 billion, or NT$1.03 per basic share, in the first quarter, according to a Thursday Taiwan Exchange filing.Shares gained about 1% in Friday's early afternoon trade.Operating revenue amounted to NT$27.8 billion, the filing stated. The telco did not provide comparative year-ago figures.

$TPE:4904
Asia

Lonza Group Delivers Strong Performance in Q1

Lonza Group (SGX:O6Z) delivered strong contract development and manufacturing organization (CDMO) growth during the first quarter of the year, according to a Friday filing with the Singapore Exchange.The Swiss pharmaceutical company expects stronger sales in the first half of 2026 compared to the second half, backed by a lower prior-year base and planned site shutdowns.The momentum in Q1 was led by strong contributions from the integrated biologics segment and improvement from the specialized modalities segment.Lonza projects sales growth of 11% to 12% at constant exchange rates for the full year 2026.Over the medium term, the dual-listed group targets average sales growth in the low teens at constant exchange rates.

$SGX:O6Z